BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

546 related articles for article (PubMed ID: 6744296)

  • 1. Metabolism of 2-acetylaminofluorene by two 3-methylcholanthrene-inducible forms of rat liver cytochrome P-450.
    Goldstein JA; Weaver R; Sundheimer DW
    Cancer Res; 1984 Sep; 44(9):3768-71. PubMed ID: 6744296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential metabolism of acetanilide versus ethoxycoumarin and benzo[a]pyrene by two 3-methylcholanthrene-inducible forms of rat liver cytochrome P-450.
    Sundheimer DW; Caveness MB; Goldstein JA
    Arch Biochem Biophys; 1983 Oct; 226(2):548-57. PubMed ID: 6314905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose response for induction of two cytochrome P-450 isozymes and their mRNAs by 3,4,5,3'4'5'-hexachlorobiphenyl indicating coordinate regulation in rat liver.
    Hardwick JP; Linko P; Goldstein JA
    Mol Pharmacol; 1985 Jun; 27(6):676-82. PubMed ID: 3923327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between oxidative metabolism of 2-acetylaminofluorene, debrisoquine, bufuralol, and aldrin in human liver microsomes.
    McManus ME; Boobis AR; Minchin RF; Schwartz DM; Murray S; Davies DS; Thorgeirsson SS
    Cancer Res; 1984 Dec; 44(12 Pt 1):5692-7. PubMed ID: 6498831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. I. Cytochrome P-450-catalyzed N-demethylation and 4-hydroxylation.
    Mani C; Gelboin HV; Park SS; Pearce R; Parkinson A; Kupfer D
    Drug Metab Dispos; 1993; 21(4):645-56. PubMed ID: 8104124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catalysis of divergent pathways of 2-acetylaminofluorene metabolism by multiple forms of cytochrome P-450.
    Johnson EF; Levitt DS; Muller-Eberhard U; Thorgeirsson SS
    Cancer Res; 1980 Dec; 40(12):4456-9. PubMed ID: 7438078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of N- and C-hydroxylations of 2-acetylaminofluorene in male Sprague-Dawley rat liver microsomes: implications for carcinogenesis.
    McManus ME; Minchin RF; Sanderson N; Wirth PJ; Thorgeirsson SS
    Cancer Res; 1983 Aug; 43(8):3720-4. PubMed ID: 6861141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of 3-methylcholanthrene on bunitrolol metabolism. Kinetics and immunological studies on 4-hydroxylation of bunitrolol catalyzed by two species of cytochromes P450 in rat liver microsomes.
    Fujita S; Masuda M; Shimamoto Y; Hoshi H; Kariya S; Kazusaka A; Suzuki T
    Drug Metab Dispos; 1996 Feb; 24(2):254-9. PubMed ID: 8742239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of cytochrome P-450 isozymes involved in the hydroxylation of dantrolene by rat liver microsomes.
    Jayyosi Z; Villoutreix J; Ziegler JM; Batt AM; De Maack F; Siest G; Thomas PE
    Drug Metab Dispos; 1993; 21(5):939-45. PubMed ID: 7902259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of isozymes of cytochrome P-450 in the metabolism of N,N-dimethyl-4-aminoazobenzene in the rat.
    Levine WG; Lu AY
    Drug Metab Dispos; 1982; 10(2):102-9. PubMed ID: 6124393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological identification and effects of 3-methylcholanthrene and phenobarbital on rat pulmonary cytochrome P-450.
    Keith IM; Olson EB; Wilson NM; Jefcoate CR
    Cancer Res; 1987 Apr; 47(7):1878-82. PubMed ID: 3545456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of cytochrome P-450 and flavin-containing monooxygenase in the N-hydroxylation of N-methyl-4-aminoazobenzene in rat liver: analysis with purified enzymes and antibodies.
    Kimura T; Kodama M; Nagata C
    Gan; 1984 Oct; 75(10):895-904. PubMed ID: 6510637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of 2-acetylaminofluorene oxidations by monoclonal antibodies specific to 3-methylcholanthrene-induced rat liver cytochrome P450.
    Thorgeirsson SS; Sanderson N; Park SS; Gelboin HV
    Carcinogenesis; 1983; 4(5):639-41. PubMed ID: 6850996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism of N-nitroso-2,6-dimethylmorpholine by isozymes of rabbit liver microsomal cytochrome P-450.
    Kokkinakis DM; Koop DR; Scarpelli DG; Coon MJ; Hollenberg PF
    Cancer Res; 1985 Feb; 45(2):619-24. PubMed ID: 3967237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positional specificity for methyl-n-amylnitrosamine hydroxylation by cytochrome P-450 isozymes determined with monoclonal antibodies.
    Mirvish SS; Huang Q; Ji C; Wang S; Park SS; Gelboin HV
    Cancer Res; 1991 Feb; 51(4):1059-64. PubMed ID: 1997155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regioselectivity and stereoselectivity in the metabolism of trans-1,2-dihydroxy-1,2-dihydrobenz[a]anthracene by rat liver microsomes.
    Vyas KP; van Bladeren PJ; Thakker DR; Yagi H; Sayer JM; Levin W; Jerina DM
    Mol Pharmacol; 1983 Jul; 24(1):115-23. PubMed ID: 6865920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of phenobarbital, dexamethasone, and 3-methylcholanthrene administration on the metabolism of 17 beta-estradiol by liver microsomes from female rats.
    Suchar LA; Chang RL; Thomas PE; Rosen RT; Lech J; Conney AH
    Endocrinology; 1996 Feb; 137(2):663-76. PubMed ID: 8593816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunochemical study on the contributions of two molecular species of microsomal cytochrome P-450 to the metabolism of benzo(a)pyrene by rat liver microsomes.
    Hara E; Kawajiri K; Tagashira Y
    Cancer Res; 1983 Aug; 43(8):3604-8. PubMed ID: 6305488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody inhibition of oxidative activation and inactivation of the carcinogen 2-acetylaminofluorene by purified hepatic cytochrome P-450 from 3-methylcholanthrene pretreated rats.
    Pandey RN; Clearfield MS; Paik SM; Lotlikar PD
    Cancer Lett; 1983 Jul; 19(3):263-71. PubMed ID: 6411328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunochemical evidence for two 3-methylcholanthrene-inducible forms of cytochrome P-448 in rat liver microsomes using a double-antibody radioimmunoassay procedure.
    Luster MI; Lawson LD; Linko P; Goldstein JA
    Mol Pharmacol; 1983 Jan; 23(1):252-7. PubMed ID: 6408389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.